You've never seen anything like it · Doors open inStarts at 7:00 PM ET
Skip to content

Research peptide · Tissue research

ARA-290

A synthetic 11-residue peptide, also called cibinetide, whose sequence corresponds to the helix B surface region of erythropoietin and which begins with an N-terminal pyroglutamate.

Compound type
Research peptide
Research area
Tissue
Formula
C51H84N16O21
Average mass
1,257.307 Da
Monoisotopic mass
1,256.5997 Da
Length
11 residues

What it is

ARA-290 is a synthetic linear peptide of eleven residues: pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser, written in one-letter code as pEQLERALNSS. Its molecular formula is C51H84N16O21 and its average molecular weight is 1257.3 g/mol. It carries CAS number 1208243-50-8 and PubChem CID 91810664, and appears in the literature under the names cibinetide, ARA 290 and pHBSP.

The sequence is not a synthetic invention in the way that ipamorelin's is. It corresponds to a solvent-exposed stretch of erythropoietin, the glycoprotein hormone whose four-helix bundle fold contains the region conventionally called helix B. The alias pHBSP is an abbreviation of that derivation: pyroglutamate helix B surface peptide. ARA-290 reproduces the surface residues of that region as a short linear chain, without the rest of the protein scaffold and without erythropoietin's glycosylation.

Discovery and origin

The peptide originates from structure-guided work on erythropoietin in which distinct surfaces of the folded protein were mapped to distinct receptor interactions, and short peptides were designed to reproduce one surface at a time. ARA-290 is the pyroglutamate-capped version of the helix B surface segment. It was developed as a research compound and has carried the code ARA-290 and the international nonproprietary name cibinetide since then.

The material supplied here is produced by solid-phase peptide synthesis rather than by recombinant expression.

Structure and chemistry

The composition is strongly polar and strongly acidic. Three glutamate residues and the N-terminal pyroglutamate give the chain a pronounced net negative charge at neutral pH, offset only by the single arginine. There is no cysteine, so the peptide has no disulfide bond and no oxidation-prone thiol, and the sequence contains no aromatic residues, so the molecule lacks a tryptophan or tyrosine chromophore and must be detected by low-wavelength ultraviolet absorbance of the peptide bond itself, near 214 nm, rather than at 280 nm.

The N-terminal pyroglutamate is the defining chemical feature. Pyroglutamate is a cyclized glutamine or glutamate residue in which the side chain has condensed onto the alpha-amino group to form a five-membered lactam. The practical consequences are that the peptide has no free N-terminal amine, so it does not respond to standard Edman sequencing without prior enzymatic uncapping, and that it is not susceptible to aminopeptidase cleavage at its first residue. Peptides containing N-terminal glutamine or glutamate can cyclize spontaneously during synthesis and storage, so for this sequence the pyroglutamate is designed in rather than treated as an impurity.

The C-terminus is the other point to watch. The asparagine at position nine, followed directly by serine, sits in a classic deamidation motif, converting to aspartate with a mass shift of about one unit.

How it is studied in the laboratory

This profile cites no preclinical literature for ARA-290. Published in vitro, cell-based, animal and structural literature on this compound is limited, so this profile keeps to its chemistry and identity. Rather than describe work that is not cited, the section is left deliberately empty of claims.

What can be said without a citation is a matter of identity and laboratory logistics: ARA-290 is a defined, fully synthetic sequence of known mass and composition, and researchers working with it characterize identity and purity before use, as they would for any synthetic peptide standard.

Analytical notes

Identity is confirmed by liquid chromatography coupled to mass spectrometry. On the average mass of 1257.3 g/mol, the expected doubly protonated ion falls near m/z 629.66 and the triply protonated ion near m/z 420.11. A monoisotopic calculation on 1256.60 places those ions near 629.31 and 419.87, so the certificate should state which mass convention it uses before a deviation of a few tenths is treated as a discrepancy. Given the acidic composition, negative-mode ionization is often the more sensitive option and gives a clean [M-2H]2- series.

Purity is assessed by reversed-phase HPLC. With no aromatic side chains, detection is at 214 nm or below, which raises the baseline contribution of the mobile phase and makes solvent quality more consequential than it is for a peptide with a tryptophan or naphthylalanine chromophore. The impurities worth resolving are the deamidated Asn9 form, which differs by about one mass unit and typically elutes slightly earlier, deletion sequences from incomplete couplings, and any uncyclized glutamate form at the N-terminus, which carries a free amine and a mass eighteen units higher. Residual trifluoroacetate from purification is measured separately when a counter-ion-free preparation is needed.

Storage and handling in the laboratory

As supplied, the material is a lyophilized white powder that is soluble in water. It is stored at -20 degrees Celsius and protected from light. The acidic, serine-rich composition makes the dry state substantially more stable than any solution, and deamidation at the asparagine proceeds faster at alkaline pH and elevated temperature, so laboratories holding working solutions generally keep them cold, near neutral or slightly acidic, and for as short a period as the work allows. The vial is best brought to room temperature before opening so that moisture does not condense onto cold powder.

Open questions in the literature

No experimental structure of ARA-290 has been published, and short linear peptides of this length rarely hold a stable conformation free in solution, so how faithfully the sequence reproduces the geometry of the corresponding surface in the folded parent protein is an open structural question. Quantitative data on the solution stability of the peptide, in particular the rate of deamidation at Asn9 across the pH and temperature range used at the bench, are not available in the public literature.

Identity check

A mass-spectrometry result for ARA-290 should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.

IonExpected m/z
[M+H]+1257.61
[M+2H]2+629.31

For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.